van der Ploeg, Esmee K.
Krabbendam, Lisette http://orcid.org/0000-0001-9679-8376
Vroman, Heleen
van Nimwegen, Menno
de Bruijn, Marjolein J. W.
de Boer, Geertje M. http://orcid.org/0000-0002-9615-1123
Bergen, Ingrid M.
Kool, Mirjam http://orcid.org/0000-0003-1436-3876
Tramper-Standers, Gerdien A. http://orcid.org/0000-0002-0228-5375
Braunstahl, Gert-Jan http://orcid.org/0000-0001-7671-3742
Huylebroeck, Danny http://orcid.org/0000-0003-4862-1079
Hendriks, Rudi W. http://orcid.org/0000-0003-2291-0382
Stadhouders, Ralph http://orcid.org/0000-0002-1060-5607
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vidi 09150172010068)
Erasmus Medisch Centrum (Fellowship)
Dutch Lung Foundation
Article History
Received: 14 January 2022
Accepted: 11 August 2023
First Online: 23 August 2023
Competing interests
: G.J.B. and G.A.T. declare the following competing interests: G.J.B. has received grant/research support for consultations and/or speaking at conferences from Novartis, GSK, AstraZeneca, ALK, Teva, Sanofi, and Chiesi. G.A.T. has received research support and consultation fees from OM Pharma, AstraZeneca, and Chiesi, all paid to a research foundation. The remaining authors declare no competing interests.